McMillion Capital Management’s Gilead Sciences GILD Stock Holding History

McMillion Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$1.93K	Buy	+25	New	+$1.99K	﹤0.01%	181
2022 Q4	–	Sell	-25	Closed	-$2K	–	117
2022 Q3	$2K	Hold	25	–	–	﹤0.01%	192
2022 Q2	$2K	Buy	+25	New	+$1.55K	﹤0.01%	204
2021 Q1	–	Sell	-94	Closed	-$5K	–	156
2020 Q4	$5K	Buy	+94	New	+$5.67K	﹤0.01%	238
2020 Q2	–	Sell	-69	Closed	-$5K	–	144
2020 Q1	$5K	Hold	69	–	–	﹤0.01%	233
2019 Q4	$4K	Hold	69	–	–	﹤0.01%	240
2019 Q3	$4K	Hold	69	–	–	﹤0.01%	236
2019 Q2	$5K	Buy	+69	New	+$4.54K	﹤0.01%	236

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

McMillion Capital Management's GILD Position: Q2 2023 in Review

McMillion Capital Management opened a new position in Gilead Sciences (GILD) in Q2 2023: 25 shares worth $1.93K. The stake represents ﹤0.01% of the portfolio and ranks #181 among its holdings. This is a return to the name: McMillion Capital Management previously reported a position in GILD as recently as Q3 2022.

McMillion Capital Management first reported a position in GILD in Q2 2019 and has held it in 8 quarters since. The position peaked at $5K in Q4 2020. 1,702 funds tracked by Wall St. Rank hold GILD as of Q2 2023.

McMillion Capital Management held 25 shares of Gilead Sciences worth $1.93K as of Q2 2023.
Gilead Sciences was a new McMillion Capital Management position in Q2 2023.
Gilead Sciences made up ﹤0.01% of McMillion Capital Management's portfolio in Q2 2023, its #181 holding.
McMillion Capital Management first reported a position in Gilead Sciences in Q2 2019 and has held it in 8 quarters since.
McMillion Capital Management's Gilead Sciences position peaked at $5K in Q4 2020.
1,702 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2023.

Based on McMillion Capital Management's 13F filing for Q2 2023, filed 8 Aug 2023.